The Trend, Feasibility, and Safety of Salpingectomy as a form of Permanent Sterilization.
暂无分享,去创建一个
Han-Yang Chen | A. Barberio | U. Acholonu | S. Chang-Jackson | P. Berens | A. Kim | S. Gants | L. Swilinski
[1] P. Coyte,et al. The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer. , 2017, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[2] Sarah L. Cohen,et al. Review of Sterilization Techniques and Clinical Updates. , 2017, Journal of minimally invasive gynecology.
[3] R. Littell,et al. Salpingectomy for Sterilization: Change in Practice in a Large Integrated Health Care System, 2011-2016. , 2017, Obstetrics and gynecology.
[4] L. K. Ely,et al. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis. , 2017, Journal of minimally invasive gynecology.
[5] Jason D. Wright,et al. Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women , 2017, Cancer investigation.
[6] M. Creinin,et al. Safety outcomes of female sterilization by salpingectomy and tubal occlusion. , 2015, Contraception.
[7] A. Jemal,et al. Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.
[8] S. Khadilkar,et al. Global trends in use of long‐acting reversible and permanent methods of contraception: Seeking a balance , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[9] R. Kulier,et al. Techniques for the interruption of tubal patency for female sterilisation. , 2015, The Cochrane database of systematic reviews.
[10] D. Huntsman,et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. , 2014, American journal of obstetrics and gynecology.
[11] E. Carey,et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. , 2013, Fertility and sterility.
[12] C. Landen,et al. The role of the fallopian tube in the origin of ovarian cancer. , 2013, American journal of obstetrics and gynecology.
[13] M. Diamond,et al. Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database. , 2013, Journal of minimally invasive gynecology.
[14] N. Gleeson,et al. Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC). , 2013, European journal of obstetrics, gynecology, and reproductive biology.
[15] A. Mes-Masson,et al. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. , 2013, Journal of minimally invasive gynecology.
[16] J. Gohagan,et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.
[17] M. Widschwendter,et al. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. , 2011, Human reproduction update.
[18] S. Bollapragada,et al. Spontaneous pregnancy after bilateral salpingectomy. , 2005, Fertility and sterility.
[19] H. Peterson,et al. Complications of Interval Laparoscopic Tubal Sterilization: Findings From the United States Collaborative Review of Sterilization , 2000, Obstetrics and gynecology.
[20] H. Peterson,et al. Requesting information about and obtaining reversal after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. , 2000, Fertility and sterility.